Specialty code 1835P2201X · Lincoln, CA
NPI
1659812253
Since 2017
Specialty
Specialty code 1835P2201X
Code 1835P2201X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1900 Dresden Dr
Lincoln, CA, 95648
Phone (916) 543-5466
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$228K
2,637 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Janelle Stevens prescribed most often to Medicare patients was Atorvastatin Calcium, with 520 prescriptions and refills. In total Janelle Stevens wrote 2,637 Medicare prescriptions that cost $228K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-24.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 520 | 1,731 | 207 | $6,208 |
| Metformin Hcl Er Metformin Hcl | 294 | 973 | 131 | $2,892 |
| Metformin Hcl Generic | 195 | 650 | 76 | $2,580 |
| Glipizide Generic | 163 | 542 | 72 | $2,482 |
| Jardiance Empagliflozin | 128 | 426 | 65 | $79K |
| Glimepiride Generic | 127 | 421 | 50 | $2,317 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 115 | 365 | 58 | $3,563 |
| Humulin N Insulin Nph Human Isophane | 97 | 296 | 52 | $19K |
| Insulin Glargine-Yfgn Generic | 97 | 286 | 52 | $17K |
| Losartan Potassium Generic | 87 | 290 | 39 | $1,072 |
| Rosuvastatin Calcium Generic | 83 | 277 | 29 | $969 |
| Lisinopril Generic | 81 | 268 | 36 | $997 |
| Simvastatin Generic | 75 | 250 | 30 | $875 |
| Amlodipine Besylate Generic | 64 | 213 | 29 | $823 |
| Humulin R Insulin Regular, Human | 54 | 163 | 23 | $11K |
Brand drugs: 532 claims; generic drugs: 1,936 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Janelle Stevens were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.